## Line Chart: Performance Comparison of Different Methods Across Max Rollout Steps
### Overview
This image is a line chart comparing the performance (in percentage) of five different methods or algorithms as a function of the "Max Rollout" parameter. The chart tracks how each method's performance changes as the maximum rollout value increases from 1 to 10.
### Components/Axes
* **Chart Type:** Multi-line chart with markers.
* **X-Axis:**
* **Label:** "Max Rollout"
* **Scale:** Linear, integer values from 1 to 10.
* **Markers:** Ticks and labels at every integer from 1 to 10.
* **Y-Axis:**
* **Label:** "Performance (%)"
* **Scale:** Linear, ranging from 30 to 70.
* **Markers:** Major ticks and labels at intervals of 5 (30, 35, 40, 45, 50, 55, 60, 65, 70).
* **Legend:**
* **Position:** Top-left corner of the plot area.
* **Content:** Five entries, each with a colored line, marker symbol, and text label.
1. **Green line with circle markers:** "Ours"
2. **Red line with upward-pointing triangle markers:** "SRA-MCTS"
3. **Purple line with star markers:** "SRA-MCTS_no_eg"
4. **Blue line with square markers:** "LDB"
5. **Orange line with diamond markers:** "ToT"
### Detailed Analysis
The performance of each method at each Max Rollout value is extracted below. Values are approximate based on visual inspection of the chart.
**Trend Verification & Data Points:**
| Max Rollout | Ours (%) | ToT (%) | LDB (%) | SRA-MCTS_no_eg (%) | SRA-MCTS (%) |
| :---------- | :------- | :------ | :------ | :----------------- | :----------- |
| 1 | 54 | 41.5 | 40 | 42 | 37 |
| 2 | 53.5 | 47 | 44 | 43 | 39 |
| 3 | 57 | 55 | 41 | 45 | 45 |
| 4 | 61 | 53 | 47 | 43 | 43 |
| 5 | 59.5 | 57.5 | 47.5 | 45.5 | 44 |
| 6 | 58 | 56 | 50.5 | 46 | 46 |
| 7 | 62 | 56 | 49 | 46 | 43.5 |
| 8 | 61 | 53 | 50.5 | 41.5 | 44 |
| 9 | 61 | 55.5 | 50 | 45.5 | 41.5 |
| 10 | 63 | 55 | 50 | 45 | 41.5 |
**Trend Descriptions:**
1. **Ours (Green, Circle):**
* **Trend:** Generally upward sloping with minor fluctuations. Starts as the highest performer and maintains the lead throughout.
2. **ToT (Orange, Diamond):**
* **Trend:** Sharp initial increase, then plateaus with fluctuations. Consistently the second-highest performer after Rollout 2.
3. **LDB (Blue, Square):**
* **Trend:** Moderate upward trend with some volatility. Generally occupies the middle tier.
4. **SRA-MCTS_no_eg (Purple, Star):**
* **Trend:** Relatively flat with minor oscillations. Performs similarly to SRA-MCTS initially but shows more stability in the mid-range.
5. **SRA-MCTS (Red, Up-Triangle):**
* **Trend:** Slight upward trend initially, then declines after Rollout 6. Generally the lowest-performing method.
### Key Observations
1. **Clear Hierarchy:** A consistent performance hierarchy is visible: "Ours" > "ToT" > "LDB" > "SRA-MCTS_no_eg" & "SRA-MCTS".
2. **"Ours" Dominance:** The "Ours" method not only starts highest but also shows the strongest positive trend, achieving the highest overall performance (~63%) at Max Rollout 10.
3. **ToT's Early Jump:** "ToT" shows the most dramatic single improvement, jumping from ~41.5% to ~55% between Rollout 1 and 3.
4. **Convergence and Crossover:** Around Rollout 3, "SRA-MCTS" briefly catches up to "SRA-MCTS_no_eg". "LDB" and "SRA-MCTS_no_eg" have similar values at several points (e.g., Rollout 5, 6).
5. **Stability vs. Volatility:** "SRA-MCTS_no_eg" is relatively stable. "LDB" and "ToT" show moderate volatility. "Ours" and "SRA-MCTS" show more pronounced peaks and valleys.
### Interpretation
This chart likely presents results from a research paper or technical report comparing a proposed method ("Ours") against several baselines ("SRA-MCTS", "LDB", "ToT") and an ablated version of a baseline ("SRA-MCTS_no_eg").
* **What the data suggests:** The primary conclusion is that the proposed method ("Ours") is superior, achieving higher performance than all compared methods across nearly all rollout budgets. Its advantage becomes more pronounced at higher rollout values.
* **Relationship between elements:** The "Max Rollout" parameter likely controls computational budget or search depth. The chart demonstrates how efficiently each method converts increased budget into performance gains. "Ours" and "ToT" show good scaling, while "SRA-MCTS" scales poorly after a certain point.
* **Notable anomaly:** The "_no_eg" suffix on one SRA-MCTS variant suggests an ablation study where a component (possibly "eg" for "example guidance" or similar) was removed. The fact that this variant often outperforms the standard "SRA-MCTS" is counter-intuitive and would require reading the associated paper to understand. It might indicate that the removed component was detrimental in this specific evaluation setting or that its interaction with the rollout parameter is complex.
* **Underlying message:** The visualization is designed to convincingly argue for the effectiveness and robustness of the "Ours" method, showing it is not only best on average but also maintains its lead under varying conditions (different rollout limits).
